Global Healthcare Analytics Market
Dublin, Jun 3, 2022 (GLOBE NEWSWIRE) – “Global Healthcare Analytics Market Size, Share and Industry Trends Analysis Report by Component, by Type, by End User, by Deployment Model, by Application, by Regional Outlook and Forecast, 2021-2027 A report has been added to ResearchAndMarkets.com Show.
The global healthcare analytics market size is expected to reach US$93.3 billion by 2027, growing at a compound annual growth rate of 28.8% over the forecast period.
Healthcare Analytics is the effective use of new applied analytical models, statistical, predictive, quantitative, comparative, cognitive, of relevant business data and insights. Additionally, healthcare analytics technologies can help extract and understand historical data patterns, predict future outcomes, and provide actionable insights to help healthcare companies make better clinical, financial, and operational decisions. In addition, analytics helps healthcare organizations reduce costs and improve quality of care.
In recent years, there has been an increasing use of analytical solutions in this sector, such as creating databases and historical patterns using descriptive analysis, and estimating future market dynamics and outcomes using predictive and educational analysis. Furthermore, social media and the Internet have a significant impact on the healthcare business in terms of raising awareness and data collection for patient engagement methods. The healthcare analytics market is driven by the growing demand to improve patient outcomes while reducing costs through the use of data analytics.
The development of advanced analytical solutions tailored to meet the specific needs of healthcare organizations and facilities providing financial, operational, clinical and management services fuels industry growth. In addition, one of the main trends of the industry is the boom in the use of data mining and big data analytics techniques to study high-risk groups and design solutions. Government agencies and financial institutions use predictive analytics solutions for a variety of purposes, including assessing risk and reducing payment fraud.
The demand for personalized medicine catering to different human genome combinations is growing, and data-rich tools are increasingly used to improve patient care, such as electronic health records, portable health, and electronic medical records (EMRs). Additionally, health data mining uses AI solutions encapsulated in data analytics solutions to enable customized treatment plans, which is expected to create a demand for analytics solutions.
Analysis of the impact of COVID-19
The COVID-19 pandemic is wreaking havoc on the world’s population and economy. The importance of big data in healthcare has increased as a result of the pandemic. Predictive and educational analytics have been used to create prediction models for the onset of the next waves of the COVID-19 pandemic in different parts of the world.
During the pandemic, the adoption of electronic health records has increased in both developing and developed countries, impacting market growth in 2020. During the pandemic, operational analytics have proven useful in managing patient data and allocating COVID-19 beds in intensive care units. For COVID-19 patients, claims management analyzes and risk assessment have been used extensively in healthcare reimbursement.
Market Growth Factors:
The use of electronic health records is increasing in both developing and developed countries
Government support for technological advancements in the healthcare sector is boosting the healthcare analytics market. In addition, significant amounts of money are being invested in digital healthcare organizations to develop a variety of products and solutions, including health applications, IoT-based healthcare systems, electronic health records, and big data analytics. Due to the guaranteed ROI and significant benefits of this technology, both the government and venture capital firms are investing heavily in the healthcare industry. The use of electronic health records in many countries is still in its infancy. In addition, stakeholders and government have taken several measures to encourage the adoption of electronic health records in India in order to make it a national standard.
Value-based therapies are becoming more and more popular
Value-based medicine, according to the American Journal of Managed Care, is the practice of medicine based on the objective value (increased longevity and/or quality of life) conveyed by health care interventions as measured by a set of specific metrics (commonly used to assess value and cost-effectiveness). The upcoming healthcare trends will be more quality-oriented, with an emphasis on improving service quality and developing innovative approaches to value-based medicine and care management. In addition, most hospitals are gradually realizing the shortcomings of traditional patient care, quality assurance, and cost management systems. As a result, hospitals are increasingly investing in logistics management, HIE, and disease prediction analytics are expected to include healthcare BI solutions as a top priority.
Marketing Restriction Factor:
Huge initial investment needed for analytics solutions
Despite the recognized benefits of analytics in healthcare organizations, due to the high installation and subscription/licensing fees for advanced analytics solutions, adoption is low among price-sensitive end users. This is because only top-tier hospitals have the capacity and resources to properly use big data to give actionable insights. Moreover, there is still a significant dearth of qualified professionals who can properly manage these solutions, which can pose a challenge to industry players. Additionally, implementing healthcare analytics solutions in-house developed can be a big deal, along with additional annual subscription/licensing fees.
Main topics covered:
Chapter 1. Market Scope and Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market and Scenario Configuration
2.2 Main factors affecting the market
2.2.1 Market Drivers
2.2.2 Market Restrictions
Chapter 3. Competition Analysis – Global
3.1 Publisher Cardinal Matrix
3.2 Recent strategic developments at the industry level
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product launches and product expansions
3.2.3 Acquisition and Merger
3.3 The most important profit strategies
3.3.1 Key Leading Strategies: Relative Distribution (2017-2021)
3.3.2 Key strategic move: (Partnerships, Agreements and Collaboration: 2018, March – 2021, November) Key players
Chapter 4. Global Healthcare Analytics Market by Component
4.1 Global services market by region
4.2 Global Software Market by Region
4.3 Global Hardware Market by Region
Chapter 5. Global Healthcare Analytics Market by Type
5.1 Global Descriptive Analytics Market by Region
5.2 Global Predictive Analytics Market by Region
5.3 Global Prescriptive Analytics Market by Region
5.4 Global Cognitive Analytics Market by Region
Chapter 6. Global Healthcare Analytics Market by End User
6.1 Global Life Sciences Companies Market by Region
6.2 Global Healthcare Payers Market by Region
6.3 Global Healthcare Providers Market by Region
Chapter 7. Global Healthcare Analytics Market by Deployment Model
7.1 Global workplace market by region
7.2 Global market on demand by region
Chapter 8. Global Healthcare Analytics Market by Application
8.1 Global Financial Analytics Market by Region
8.2 Global Clinical Analytics Market by Region
8.3 Global Operational and Management Analytics Market by Region
8.4 Global Population Health Market by Region
Chapter 9. Global Healthcare Analytics Market by Region
Chapter 10. Company Profiles
10.1 IBM
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional and Sectoral Analysis
10.1.4 Research and development expenditures
10.1.5 Recent Strategies and Developments:
10.1.5.1 Partnerships, Collaborations and Agreements:
10.1.6 SWOT Analysis
10.2 Oracle Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Sectoral and Regional Analysis
10.2.4 Research and development expenditures
10.2.5 Strategies and Recent Developments:
10.2.5.1 Partnerships, Collaborations and Agreements:
10.2.6 SWOT Analysis
10.3 Verrisk Analytics, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental analysis
10.3.4 Research and development expenditures
10.3.5 Recent Strategies and Developments:
10.3.5.1 Partnerships, Collaborations and Agreements:
10.3.5.2 Acquisitions and Mergers:
10.4 IQVIA Holdings, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Sector and Regional Analysis
10.4.4 Recent Strategies and Developments:
10.4.4.1 Partnerships, Collaborations and Agreements:
10.4.4.2 Product launches and product expansions:
10.5 AllScripts Healthcare Solutions, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional and Sectoral Analysis
10.5.4 Research and development expenditures
10.5.5 Recent Strategies and Developments:
10.5.5.1 Partnerships, Collaborations and Agreements:
10.6 McKesson Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental Analysis
10.6.4 R&D Expenditure
10.6.5 Recent Strategies and Developments:
10.6.5.1 Partnerships, Collaborations and Agreements:
10.6.5.2 Acquisitions and Mergers:
10.6.5.3 Product launches and product expansions:
10.7 UnitedHealth Group, Inc. (Optum, Inc.)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental Analysis
10.7.4 Strategies and recent developments:
10.7.4.1 Partnerships, Collaborations and Agreements:
10.7.4.2 Product launches and product expansions:
10.8 Health Catalyst, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental Analysis
10.8.4 Research and development expenditures
10.8.5 Recent Strategies and Developments:
10.8.5.1 Partnerships, Collaborations and Agreements:
10.8.5.2 Acquisitions and Mergers:
10.8.5.3 Product launches and product expansions:
10.9 Cerner Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research and development expenditures
10.9.5 Strategies and Recent Developments:
10.9.5.1 Partnerships, Collaborations and Agreements:
10.9.5.2 Acquisitions and Mergers:
10.9.5.3 Product launches and product expansions:
10.10. SAS Institute, Inc.
10.10.1 Company Overview
10.10.2 Recent Strategies and Developments:
10.10.2.1 Partnerships, Collaborations and Agreements:
10.10.2.2 Acquisitions and Mergers:
For more information on this report, visit https://www.researchandmarkets.com/r/u0b1jz
Attached
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
#Global #Healthcare #Analytics #Market #Overview #Based #Therapies #Popular
